Agenus - mark

At Agenus, we believe the best path for treating disease is through activating our own body’s natural mechanisms.

That’s why for 20 years, we’ve focused on building technologies and a product pipeline aimed at treating cancer and infectious disease by helping the body’s immune system target diseased cells with precision.

  • 22 Jun 2015

    Agenus to Webcast Annual Meeting of Stockholders
    Read More

     

  • 18 Jun 2015

    Agenus to Present at the 2015 JMP Securities Life Sciences Conference
    Read More

     

  • 17 Jun 2015

    Agenus Appoints C. Evan Ballantyne as Chief Financial Officer
    Read More

     

  • 03 Jun 2015

    Merck Extends Immuno-Oncology Collaboration with Agenus
    Read More

     

  • 01 Jun 2015

    Updated Phase 2 Data of Prophage In Newly Diagnosed GBM Presented at ASCO Show Improvement in Median Progression Free Survival and Overall Survival...
    Read More

     

  • 28 May 2015

    Agenus to Present at the Jefferies 2015 Healthcare Conference
    Read More

     

  • 28 May 2015

    Agenus to Present at the Jefferies 2015 Healthcare Conference
    Read More